The discomfort of gynecological exams, the stigma of sexuality, the lack of access to healthcare, all lead to a neglect of cervical cancer detection and treatment. Yet cervical cancer is the second most common cancer in Indian women.
Columbia Global Centers | Mumbai and the Herbert Irving Comprehensive Cancer Center invite you to join our panel of experts on a critical discussion around the importance of cervical cancer screening and preventive vaccination. Our distinguished speakers will share the status and need for early detection and preventive measures, and deliberate upon the social and medical barriers in implementing cervical cancer screening and HPV vaccines in India and the world.
● Louise Kuhn, Professor of Epidemiology, Mailman School of Public Health ● Sharmila Pimple, Professor, Preventive Oncology, Tata Memorial Hospital
About the Speakers
Louise Kuhn is Professor of Epidemiology in the Gertrude H. Sergievsky Center, Columbia University Irving Medical Center, New York. Her research is focused on how to improve cervical cancer screening programs for women living in low- and middle-income countries, including for women living with HIV. She conducts epidemiologic and clinical research in collaboration with colleagues in South Africa and elsewhere. Her current studies include evaluation of point-of-care HPV tests and investigation of novel digital imaging technologies.
Sharmila Pimple is Professor and Physician in the Department of Preventive Oncology at the Tata Memorial Hospital, Mumbai. She is also currently the Head of WHO IND 59 group of the WHO Collaborating Centre for Cancer Prevention, Control, Screening and Early Detection. Dr. Pimple has been a part of numerous research projects and clinical trials ranging from HPV vaccination research, low-cost techniques for cervical cancer screening, artificial intelligence and assisted technologies in common cancer screening and oral cancer research. She has been a recipient of various national and international awards for her work in the field of cancer research and public health and has made key contributions in various national cancer screening, control, and capacity building programs.